Actinium Pharmaceuticals, Inc. and Action Stock Transfer Corporation, as Warrant Agent Warrant Agency Agreement Dated as of [ ] WARRANT AGENCY AGREEMENTWarrant Agency Agreement • February 15th, 2018 • Actinium Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of [ ] (“Agreement”), between Actinium Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Action Stock Transfer Corporation (the “Warrant Agent”).
ACTINIUM PHARMACEUTICALS, INC.Dealer-Manager Agreement • February 15th, 2018 • Actinium Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The following (this “Agreement”) will confirm our agreement relating to the proposed rights offering (the “Rights Offering”) to be undertaken by Actinium Pharmaceuticals, Inc., a Delaware corporation (the “Company”), pursuant to which the Company will distribute to holders of record of its common stock, par value $0.001 per share (the “Common Stock”) and to holders of certain of its outstanding warrants to purchase approximately 21,608,333 shares of Common Stock, issued on August 2, 2017 and February 11, 2015 (the “Participating Warrants”), who are entitled to participate in such offering pursuant to the terms of such warrants, subscription rights (the “Rights”) to subscribe for up to an aggregate of 35,714,285 units (the “Units”), each Unit consisting of (i) one share of Common Stock (the “Rights Shares”), (ii) 0.25 Series A Warrants (the “Series A Warrants”), with each whole Series A Warrant representing the right to purchase one share of Common Stock at an exercise price of $0.90 pe
